Epigenetics Market: Current Analysis and Forecast (2021-2027)

$3500$6860

Emphasis on Product (Enzymes, Instruments, Kits, Reagents, Others); Application (Oncology, Metabolic Diseases, Immunology, Developmental Biology, Cardiovascular Diseases, Others); End-User (Pharmaceutical & Biotechnology, Academic & Research Institutes, Contract Research Organizations, Others); Region and Country

Pages:

162

Table:

63

Figure:

127

Report ID:

UMHE21331

Geography:

Clear
  Get a Free Sample
SKU: UMHE21331 Category:
Report Description
Table of content
Research Methodology

Report Description

Global Epigenetics Market was valued at US$ XX billion in 2020 and is anticipated to reach US$ XX billion by 2027 displaying an elevated CAGR of XX% over the forecast period (2021-2027). Epigenetics is a stream of genetics that involves the study of how the cells control gene activity without altering the sequence of DNA i.e., these modifications bring out only phenotypic changes in an organism rather than genotypic change. Epigenetic changes are basically the modifications in DNA that regulate whether genes are turned on or off. These alterations are dynamic and are stable enough to pass from one generation to another.

The epigenetics market is growing exponentially on account of growth in mortality rates and incidences of cancer and other chronic diseases coupled with the heavy demand for medicines across the world. For instance, according to the World Health Organization, cancer is one of the leading causes of death globally, accounting for nearly 9.6 million deaths in 2018. this number has been increased and has reached around 10 million deaths globally in 2020. consequently, scientists across the world are carrying out high-level research on cancer therapeutics and diagnostics including research on epigenetics biomarkers as many recent studies suggest that epigenetic changes correlate with cancer development

Furthermore, the reduced sequencing cost is also anticipated to boost market growth. The cost of whole-genome sequencing has dropped promptly over the last decade with the emergence of next-generation sequencing. Additionally, with rapid technological advancement and rising investment in the research & development of pharmaceutical & biotechnology companies, the epigenetics market is witnessing an uptick all over the globe. For instance, The Pharmaceutical Research and Manufacturers of America (PhRMA) trade group represents the leading biopharmaceutical research companies in the United States. In 2019, the research and development (R&D) expenditure of its member companies reached USD 83 billion worldwide, up from USD 79.6 billion in 2018.

Distribution of Cancer Incidence Worldwide (%), 2020, By Gender

Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, Merck & co, Abcam PLC, Active Motif, and Diagenode are some of the prominent players operating in the global epigenetics market. Several M&A’s along with partnerships have been undertaken by these players to develop new and advanced epigenetics products.

Insights Presented in the Report

“Amongst product, kits segment holds the major share”

Based on products & services, the market is fragmented into enzymes, instruments, kits, reagents, and others. The kits segment generated revenue of USD XX million in 2020 and is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F owing to the growing adoption of epigenetics procedures and increase in the launch of new and advanced epigenetics kits by major industry players. For instance, in 2020, Bio-synergy, an award-winning supplements and sports nutrition company launched the world’s first-ever combined DNA & Epigenetic testing kit that provides individuals with custom-made health, performance and lifestyle advice based on their specific genetic makeup. Further, this segment is also sub-segmented into ChIP-sequencing kits, RNA sequencing kits, Bisulfite conversion kits, Whole genome amplification kits, 5-hmC & 5-mC analysis kits, and others.

“Amongst application, oncology is anticipated to grow at the highest CAGR during the analyzed period”

Based on application, the market is fragmented into oncology, metabolic diseases, immunology, developmental biology, cardiovascular diseases, and others. The oncology segment generated revenue of USD XX million in 2020. The segment is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F owing to the rising potential of epigenetics in the identification of biomarkers and growing demand for epigenetics in cancer research.

Amongst end-user, the pharmaceutical & biotechnology companies segment holds the major share”

Based on end-users, the market is fragmented into pharmaceutical & biotechnology, academic & research institutes, contract research organizations, and others. The pharmaceutical & biotechnology companies segment generated revenue of USD XX million in 2020 and is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F owing to the increase in the number of pharmaceutical & biotechnology companies across the globe. For instance, according to India Brand Equity Foundation, the domestic pharmaceutical industry in India includes a network of 3,000 drug companies and nearly 10,500 manufacturing units.

“North America signifies one of the largest markets of epigenetics Market”

For a better understanding of the market dynamics of the epigenetics market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX million in 2020 owing to period owing to wide adoption of epigenetic solutions and growing awareness among researchers regarding its application in the early detection of cancer. At the same time, Asia-Pacific is anticipated to grow at the highest CAGR of XX% during the forecast period.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

The epigenetics market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

1.1Market Definitions 
1.2Objective of the Study
1.3Limitation 
1.4Stake Holders 
1.5Currency Used in Report
1.6Scope of the Global Epigenetics Market Study

2.1 Research Methodology for the Global Epigenetics Market
2.1.1 Main Objective of the Global Epigenetics Market

MARKET SYNOPSIS

EXECUTIVE SUMMARY

5 COVID-19 IMPACT

GLOBAL EPIGENETICS MARKET REVENUE

7.1 Enzymes
7.1.1 DNA-modifying enzymes
7.1.2 Protein-modifying enzymes
7.1.3 RNA-modifying enzymes
7.2 Instruments
7.2.1 Nex-generation sequencers
7.2.2 qPCRs
7.2.3 Mass spectrometers
7.2.4 Sonicators
7.2.5 Others
7.3 Kits
7.3.1 ChIP-sequencing kits
7.3.2 RNA sequencing kits
7.3.3 Bisulfite conversion kits
7.3.4 Whole genome amplification kits
7.3.5 5-hmC & %-mC analysis kits
7.3.6 Others
7.4 Reagents
7.4.1 Antibodies
7.4.2 Buffers
7.4.3 Histones
7.4.4 Magnetic beads
7.4.5 Primers
7.4.6 Others
7.5 Others

8.1 Oncology
8.2 Metabolic diseases
8.3 Immunology
8.4 Developmental biology
8.5 Cardiovascular diseases
8.6 Others

9.1 Pharmaceutical & Biotechnology Companies
9.2 Academic & Research Institutes
9.3 Contract Research Organizations 
9.4 Others

10.1 NORTH AMERICA EPIGENETICS MARKET 
10.1.1 United States
10.1.2 Canada
10.1.3 Rest of North America
10.2 EUROPE EPIGENETICS MARKET 
10.2.1 Germany
10.2.2 France
10.2.3 United Kingdom
10.2.4 Spain
10.2.5 Italy
10.2.6 Rest of Europe
10.3 ASIA PACIFIC EPIGENETICS MARKET
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 Australia
10.3.5 Rest of Asia Pacific
10.4 REST OF THE WORLD EPIGENETICS  MARKET 

11.1 Market Drivers 
11.2 Market Challenges
11.3 Impact Analysis

12EPIGENETICS MARKET OPPORTUNITIES
13EPIGENETICS MARKET TRENDS & INSIGHTS
14LEGAL & REGULATORY FRAMEWORK

15.1 Demand Side Analysis
15.2 Supply Side Analysis
15.2.1 Top Product Launches
15.2.2 Top Business Partnerships
15.2.3 Top Merger & Acquisitions

16 VALUE CHAIN ANALYSIS

17.1 Porter’s Five forces analysis
17.1.1 Bargaining power of Supplier
17.1.2 Bargaining power of Buyer
17.1.3 Industry Rivalry
17.1.4 Availability of Substitute
17.1.5 Threat of new Entrants

18.1 Agilent Technologies
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Key Product/Services Offerings
18.1.4 Growth Strategy
18.1.5 SWOT Analysis
18.1.6 Key Financials
18.1.6.1 Revenue Split
18.1.6.2 Financial Overview of Agilent Technologies
18.1.7 Recent Developments
18.1.7.1 Product Launch
18.1.7.2 Partnerships
18.1.7.3 Business Expansion and Investments
18.1.7.4 Merger and Acquisition
18.2 Thermo Fisher Scientific
18.3 Illumina Inc
18.4 Merck & co
18.5 Abcam PLC
18.6 Active Motif
18.7 Bio-Rad
18.8 QIAGEN
18.9 Diagenode
18.1 PerkinElmer

19DISCLAIMER

Research Methodology

Analyzing the historical market, estimation of the current market, and forecasting the future market of the Global Epigenetics Market were the three major steps undertaken to create and analyze the adoption of epigenetics for the different diseases across major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of epigenetics. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size                                                                                                                                       

Step 1: In-Depth Study of Secondary Sources:

Detailed secondary study was conducted to obtain the historical market size of the epigenetics market through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the epigenetics market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments for major regions. Major segments included in the report are product, application, and end-user. Further country-level analyses were conducted to evaluate the overall utilization of epigenetics in every region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of epigenetics market. Further, we conducted factor analysis using dependent and independent variables such as increasing cancer incidence and rising government funded initiatives. A thorough analysis was conducted for demand and supply-side scenario considering top partnerships, merger and acquisition, business expansion, and product launches in the epigenetics industry across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the epigenetics market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e. top-down/bottom-up approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value (USD) and the utilization rate of epigenetics across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the epigenetics market in terms of services offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the epigenetics market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of product, application, and end-user of the epigenetics market.

Main Objective of the Epigenetics Market Study

The current & future market trends of epigenetics were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of epigenetics in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of product, application, and end-user
  • Define and analysis of the regulatory framework for the epigenetics industry
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
  • Analyze the current and forecast market size of the epigenetics market for the major region
  • Major regions studied in the report include North America (the United States and Canada), Europe (Germany, France, Italy, Spain, and United Kingdom), Asia-Pacific (China, Japan, India), and Rest of the World
  • Company profiles of the epigenetics market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry